Đang chuẩn bị liên kết để tải về tài liệu:
The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: A prospective observational multicenter study protocol (IVY)
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Paclitaxel is used in second-line conventional chemotherapies to manage patients with unresectable advanced gastric cancer (GC). Paclitaxel-induced peripheral neuropathy is a known adverse event leading to treatment discontinuation. | The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer A prospective observational multicenter study protocol IVY